LGL Group (NYSEAMERICAN:LGL) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next?

LGL Group, Inc. (The) (NYSEAMERICAN:LGL)’s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $6.87 and traded as high as $6.93. LGL Group shares last traded at $6.90, with a volume of 4,138 shares changing hands.

Analysts Set New Price Targets

Separately, Zacks Research raised LGL Group to a “hold” rating in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has a consensus rating of “Hold”.

LGL Group Stock Performance

The business has a fifty day simple moving average of $6.97 and a 200 day simple moving average of $6.87. The stock has a market cap of $45.13 million, a price-to-earnings ratio of 690.69 and a beta of 0.32.

Institutional Investors Weigh In On LGL Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Osaic Holdings Inc. lifted its position in LGL Group by 15.5% during the second quarter. Osaic Holdings Inc. now owns 20,250 shares of the industrial products company’s stock worth $154,000 after buying an additional 2,710 shares during the period. Renaissance Technologies LLC boosted its position in shares of LGL Group by 3.6% in the first quarter. Renaissance Technologies LLC now owns 166,594 shares of the industrial products company’s stock worth $1,158,000 after acquiring an additional 5,773 shares during the last quarter. Citadel Advisors LLC acquired a new stake in shares of LGL Group in the third quarter worth approximately $90,000. Finally, Gamco Investors INC. ET AL grew its holdings in LGL Group by 2.8% in the first quarter. Gamco Investors INC. ET AL now owns 670,781 shares of the industrial products company’s stock valued at $4,662,000 after purchasing an additional 18,305 shares during the period. Hedge funds and other institutional investors own 30.28% of the company’s stock.

LGL Group Company Profile

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.